JPRN-UMIN000015308已完成未知
Evaluation of anti oxidative effect of linagliptin on type 2 diabetic patients. - Evaluation of anti oxidative effect of linagliptin on type 2 diabetic patients.
linagliptin study group0 个研究点目标入组 30 人开始时间: 2014年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who started renin angiotensin system inhibitor, statin, and/or pioglitazon within 1 month
研究者
相似试验
已完成
4 期
Effect of empagliflozin/linagliptin on oxidative stress markers in chronic kidney patient with type 2 diabetes stage 3: A randomized, open label controlled trialReactive oxidative stress in T2DM with CKD stage III with HbA1c 7-10%TCTR20210322002/A48
尚未招募
3 期
A clinical trial to study the effect of antioxidants in the management of temporomandibular disordersCTRI/2022/04/042337Dr Pavithra M
已完成
不适用
Evaluation of antioxidant effects of antiepileptic drugs in adult epileptic patientsCTRI/2017/12/010840Self39
招募中
3 期
Effect of Linagliptin on Diabetic patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210812052156N1Gonabad University of Medical Sciences70
已完成
2 期
Assessment of anti-oxidant and anti-inflammatory properties of green tea in ICU patientsPneumonia.Pneumonia due to Streptococcus pneumoniae, Pneumonia due to Haemophilus influenzae, Bacterial pneumonia, not elsewhere classifiedJ15, J14,IRCT2016092529327N2Islamic Azad University of Pharmaceutical Science20